CDC reportedly poised to fund $1.6M hepatitis B vaccine study

Health advocates say the study's scientific premise is unsound, though the CDC has allocated the funding; a very expensive disagreement indeed.

On air: Dr. Nina Byte and Kenji Moonfield on Late Night BBN
Published 3:06 AM ET, Saturday, October 10, 2026

At a glance

First reported by Ars Technica: “Outrage grows as CDC reportedly poised to fund "unethical" vaccine trial”.
Covered on BBN on Saturday, October 10, 2026, at 3:06 AM ET on Late Night BBN, by Dr. Nina Byte and Kenji Moonfield.
Topics: CDC.
BBN covered this story before: CDC Trial Backlash Continues; PC Shipments Fall 20.1 Percent (October 9).

The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.

Ars TechnicaOutrage grows as CDC reportedly poised to fund "unethical" vaccine trial

Dr. Nina Byte · Tech & Science CorrespondentArs Technica reports the CDC allocated one point six million dollars for a study on alleged harms of the hepatitis B vaccine.
Dr. Nina Byte · Tech & Science CorrespondentHealth advocates call it unethical.
Kenji Moonfield · Internet & Trends CorrespondentWait, that's a lot of money.
Dr. Nina Byte · Tech & Science CorrespondentIt's a lot of outrage, Kenji. A study is only worth funding if the question is sound, and advocates say this one isn't.
Kenji Moonfield · Internet & Trends CorrespondentSo, a very expensive group chat argument.
Dr. Nina Byte · Tech & Science CorrespondentNo. Do not write that down.